Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 263-058-8 | CAS number: 61789-40-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
2 of the 1092 patients tested showed allergic reactions to test chemical. Patch test reactions to test chemical were difficult to interpret, owing to extremely common irritant reactions. Based on this observation, the test chemical can be considered to be a potentially weak skin sensitizer.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- data is from peer reviewed journals
- Qualifier:
- according to guideline
- Guideline:
- other: patch test
- Principles of method if other than guideline:
- To describe patients with positive patch test reactions to test chemical-related compounds in an occupational dermatology clinic.
- GLP compliance:
- not specified
- Type of study:
- patch test
- Justification for non-LLNA method:
- not reported
- Species:
- other: humans
- Strain:
- not specified
- Details on test animals and environmental conditions:
- Source: Finnish Institute of Occupational Health (FIOH)
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 1% in water
- Adequacy of induction:
- not specified
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 1%
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- 1092 patients
- Details on study design:
- the dermal reactions were read two or three times: on D2/D3/D4 or D2/D3/D6 or D2/D5, depending on the day of application.
- Challenge controls:
- no data available
- Positive control substance(s):
- not specified
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1% in water
- No. with + reactions:
- 2
- Total no. in group:
- 1 092
- Clinical observations:
- +++/++ reactions were observed
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- other: sensitizing
- Conclusions:
- 2 of the 1092 patients tested showed allergic reactions to test chemical. Patch test reactions to test chemical were difficult to interpret, owing to extremely common irritant reactions.Based on this observation, the test chemical can be considered to be a potentially weak skin sensitizer.
- Executive summary:
The aim of the study was to describe patients with positive patch test reactions to test chemical-related compounds in an occupational dermatology clinic between 2002 -2009. The test chemical was tested 1% in distilled water. 1092 patients were patch tested with Finn Chambers® according to the recommendations of the International Contact Dermatitis Research Group. The dermal reactions were read two or three times: on D2/D3/D4 or D2/D3/D6 or D2/D5, depending on the day of application. The patch test reactions were rated +/++/+++. 2 of the 1092 patients tested showed allergic reactions to test chemical. Patch test reactions to test chemical were difficult to interpret, owing to extremely common irritant reactions. Based on this observation, the test chemical can be considered to be a potentially weak skin sensitizer.
Reference
Patch test reactions to cocamidopropyl betaine (CAPB) and its impurities during 2002–2009 (1092 patients)
test substance (provider, vehicle) | Allergic (++/+++/+++) reactions, n(%) |
irritant reactions n(%) |
Test chemical [Chemotechnique Diagnostics], water | 2 (0.2) | 166 (5) |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In various studies,test chemical has been investigated for potential to cause dermal sensitization to a greater or lesser extent. The studies are based on in vivo experiments in humans, guinea pigs for the target chemical. The results are summarized as follows:
Study 1:
The aim of the study was to describe patients with positive patch test reactions to test chemical-related compounds in an occupational dermatology clinic between 2002 -2009. The test chemical was tested 1% in distilled water. 1092 patients were patch tested with Finn Chambers® according to the recommendations of the International Contact Dermatitis Research Group. The dermal reactions were read two or three times: on D2/D3/D4 or D2/D3/D6 or D2/D5, depending on the day of application. The patch test reactions were rated +/++/+++. 2 of the 1092 patients tested showed allergic reactions to test chemical. Patch test reactions to test chemical were difficult to interpret, owing to extremely common irritant reactions. Based on this observation, the test chemical can be considered to be a potentially weak skin sensitizer.
Study 2:
The aim of the study was to analyze whether volunteers with previous positive patch tests to test chemical would react in provocative use tests of a product containing test chemical. In order, better to differentiate irritant response from allergic reactions and also in order to reconfirm panelists’ sensitivity towards test chemical , 10 male/female volunteers were patch tested with 0.1%, 0.3%, 1.0% dilutions of test chemical. A matched control group was used. Except for a + reaction to 1% test chemical, there was no reaction to patch tests in the control group With the test chemical-sensitized group, there was a little more reactivity. 5/10 showed clear + reactions to 1% test chemical (typically at D3), whilst a further 3 gave marginal and/or irritant reactions. The observed Reactions showed a typically crescendo pattern (with no reactions at D2 but reactions occurring by D3) suggesting a true allergic reaction. Hence, the test chemical when used or tested above 1% can cause allergic reactions to humans.
Study 3:
Patch tests were performed on a total of 210 patients with clinically suspected allergic contact dermatitis to skin-care products, as well as patients with dermatitis of the head and neck area to determine the allergic potential of test chemical. The patients were patch-tested with a 1% aqueous solution of test chemical applied to small occluded patches on the backs of the patients for 48 h. Readings were performed at 48 h and at a later time, usually 96 h. Grading of reactions was done on a 0 to 3+ scale as used by the North American Contact Dermatitis Group. The patch test reactions were considered relevant to test chemical if the patient could identify one or more products containing test chemical that he or she had used before testing and if the dermatitis improved after the patient had avoided using the product. Of the 210 patients patch-tested, 12 had positive responses to test chemical, the subjects had reactions which showed up at either 48 or 96 h. The possibility of test chemical being weak allergen to pre-sensitized humans cannot be ruled out. Hence, the test chemical can be considered to be weak sensitizer to skin.
Study 4:
Magnusson and Kligman method was used to study the capacity of test chemical to induce delayed type contact dermatitis in guinea pigs. 40 albino guinea pigs of both sex were distributed evenly into 2 groups- test and vehicle control. The concentrations of test chemical were as follows - Intradermal induction - 0.1% aqueous solution, Epicutaneous induction and challenge exposure - 10% aqueous solution. The induction exposure was a 2 step process- On day 1, guinea pigs were injected with 3 pairs of injections in an area of the back. The injections comprised of 0.1 ml FCA, 0.1ml test chemical without FCA, 0.1 ml test chemical in emulsified FCA. The control groiup were treated in the same way, where the test chemical was replaced with the vehicle.7 days later, the same area was clipped and test chemical was spread along an area of 2 -4 cm, covered with an impervious tape and the torso was firmly secured with an elastic bandage. The dressing was left in place for 48 h. After 3 weeks of rest, the animals were subjected to challenge exposure. The flanks of the control and test animals were clipped, and occlusive patches of the test chemical and vehicle (control) were applied for 24 h. The test sites were evaluated for dermal reactions after 48 and 72 hours. Macroscopic examination of the animals showed erythema, edema and inflammation in 8 of the 20 guinea pigs. Microscopic evaluation showed acanthosis and massive layer of infiltration of the superficial layers of the derma with lymphomonuclears in 2 animals. These appearances showed positive showed of sensitization. Ambiguous reactions were observed in 4/20 animals. Based on the reactions observed, test chemical can be considered to be sensitizing to skin.The results of GPMT test and various patch test indicate a possibility that test chemical could have a potential to cause sensitization to skin.
Hence, the test chemical can be considered to be weak sensitizer to skin.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Available data for test chemical indicates that it is likely to induce dermal reactions. Hence,the test chemical can be considered to be sensitizing to skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
